NCT00224068View on ClinicalTrials.gov

Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Anemia
Interventions
DRUG

Sodium ferric gluconate, ferrous sulfate, standard of care

Trial Locations (32)

Unknown

Bakersfield

Chula Vista

Long Beach

Los Angeles

Norwich

Port Saint Lucie

Zephyrhills

Columbus

Coeur d'Alene

Hutchinson

Lexington

Baton Rouge

Baltimore

Detroit

Saint Joseph

Southfield

Duluth

Greenwood

Cherry Hill

Denville

Manhasset

Bismarck

Columbus

Philadelphia

Pittsburgh

West Chester

Columbia

Laredo

Richmond

Salem

Walla Walla

Milwaukee

Sponsors
All Listed Sponsors
lead

Watson Pharmaceuticals

INDUSTRY

NCT00224068 - Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy | Biotech Hunter | Biotech Hunter